Cited by

• Early death in acute promyelocytic leukemia: time to redefine risk groups.

  Salman MY, Ofran Y. Salman MY, et al. Haematologica. 2022 Jul 1;107(7):1498-1499. doi: 10.3324/haematol.2021.280446. Haematologica. 2022. PMID: 35081691 Free PMC article. No abstract available.
• Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (alliance) clinical trials.

  Castillo JJ, Mulkey F, Geyer S, Kolitz JE, Blum W, Powell BL, George SL, Larson RA, Stone RM. Castillo JJ, et al. Am J Hematol. 2016 Feb;91(2):199-204. doi: 10.1002/ajh.24230. Epub 2015 Nov 26. Am J Hematol. 2016. PMID: 26526191 Free PMC article.
• Complications during Induction Chemotherapy in Acute Promyelocytic Leukemia: An Institutional Experience.

  Yedla RP, Bala SC, Pydi VR, Chennamaneni R, Kuruva SP, Konatam ML, Gundeti S. Yedla RP, et al. South Asian J Cancer. 2022 Nov 2;12(3):274-279. doi: 10.1055/s-0042-1757303. eCollection 2023 Jul. South Asian J Cancer. 2022. PMID: 38047056 Free PMC article.
• Acute Myeloid Leukemia Acquiring Promyelocytic Leukemia-Retinoic Acid Receptor Alpha at Relapse.

  Gupta V, Shariff M, Bajwa R, Patel I, Ayyad HA, Levitt MJ, Mencel PJ, Hossain MA. Gupta V, et al. World J Oncol. 2019 Jun;10(3):153-156. doi: 10.14740/wjon1211. Epub 2019 Jun 29. World J Oncol. 2019. PMID: 31312283 Free PMC article.
• FLT3-ITD Allelic Burden and Acute Promyelocytic Leukemia Risk Stratification.

  Li AY, Kashanian SM, Hambley BC, Zacholski K, Duong VH, El Chaer F, Holtzman NG, Gojo I, Webster JA, Norsworthy KJ, Smith BD, DeZern AE, Levis MJ, Baer MR, Kamangar F, Ghiaur G, Emadi A. Li AY, et al. Biology (Basel). 2021 Mar 21;10(3):243. doi: 10.3390/biology10030243. Biology (Basel). 2021. PMID: 33800974 Free PMC article.